SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-14-348729
Filing Date
2014-09-22
Accepted
2014-09-22 17:11:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-4/A#3 d772054ds4a.htm S-4/A 1490738
2 EX-23.1 d772054dex231.htm EX-23.1 1543
3 EX-23.2 d772054dex232.htm EX-23.2 2818
4 EX-23.3 d772054dex233.htm EX-23.3 1819
5 EX-23.4 d772054dex234.htm EX-23.4 3533
6 GRAPHIC g772054g22p23.jpg GRAPHIC 11236
7 GRAPHIC g772054g27g47.jpg GRAPHIC 9225
8 GRAPHIC g772054g55e62.jpg GRAPHIC 12182
  Complete submission text file 0001193125-14-348729.txt   1547075
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-196856 | Film No.: 141114553
SIC: 2834 Pharmaceutical Preparations